drugset / Trial / NCT02752503

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

NCT02752503

NaSingle-groupOpen-labelTreatment

Summary

The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.

Timeline

Start
2015-03
Primary completion
2016-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalmefene Small molecule